Molecular Signatures to Improve Diagnosis and Outcome Pr
改善诊断和结果的分子特征
基本信息
- 批准号:7913564
- 负责人:
- 金额:$ 36.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-09-29
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsB-Cell NonHodgkins LymphomaBiological AssayCase SeriesCategoriesClassificationClinicalClinical DataDNADNA Microarray ChipDataDiagnosisDiagnosticDiseaseEvaluationFormalinGene ExpressionGene Expression ProfileGeneticGenetic DeterminismGenetic MarkersGenetic ModelsGenetic TranscriptionGrantLymphomaMS4A1 geneMicroarray AnalysisMinorModelingModificationMolecularMolecular GeneticsMolecular ProfilingNon-Hodgkin&aposs LymphomaOutcomeParaffin EmbeddingPatientsPolymerase Chain ReactionPredictive ValuePrognostic MarkerPublishingResearch PersonnelResolutionReverse TranscriptionSamplingSpecimenSubgroupSystemTestingTherapeuticTimeTissue EmbeddingTissuesTrainingTreatment ProtocolsUpdateValidationbasecohortcomparative genomic hybridizationcostdesignfollow-upimprovedlarge cell Diffuse non-Hodgkin&aposs lymphomanovel therapeuticsprognosticprograms
项目摘要
DESCRIPTION (provided by applicant):
Gene expression signatures that define the common categories of non-Hodgkin's lymphoma (NHL) have been identified, including some unique subtypes not recognized previously. Molecular prognosticators for these NHLs have also been described. We have recently developed a DNA microarray with over 2500 features, including all known diagnostic and prognostic parameters for NHL. We propose to use this array to study 2400 new cases to validate and refine current as well as newly discovered signatures and algorithms as the study progresses. Completion of this aim will provide a robust, cost-effective system for accurate diagnostic and prognostic applications. An alternative, quantitive(Q) RT-PCR based platform that can be applied to paraffin-embedded tissue will also be developed. It will incorporate the essential information from of the microarray platform and allow the assessment of critical parameters in specimens not specifically collected for microarray analysis, hence greatly expanding the utility of the information. There is evidence that genetic data may provide additional prognostic information to the current gene expression-derived prognosticators. We propose to obtain comprehensive, high-resolution molecular genetic data on diffuse large B-cell lymphoma to examine if the combination of genetic and gene expression parameters will improve the current prognostic model. Since existing prognosticators were derived from the study of archival cases prior to the availablility of anti-CD20 therapy, they will be re-evaluated in patients treated with current therapeutic regimens. Modifications will be made to maintain the accuracy of the prognosticators. This study will not only validate previously-defined diagnostic and prognostic signatures, but will further refine the signatures and algorithms for higher accuracy and robustness. The range of application will be expanded by adapting the information to a Q-RT-PCR platform. Prognosticators will be enhanced by the incorporation of genetic data, and updated by a re-evaluation of cohorts of patients treated with current therapeutic regimens.
描述(由申请人提供):
已经确定了定义非霍奇金淋巴瘤(NHL)常见类别的基因表达特征,其中包括先前未识别的一些独特的亚型。这些NHL的分子预后也已经描述了。我们最近开发了一个具有2500多个功能的DNA微阵列,包括所有已知的NHL诊断和预后参数。我们建议使用此阵列研究2400例新病例,以验证和完善当前的速度以及新发现的特征和算法,随着研究的进行。此目标的完成将为准确的诊断和预后应用提供强大的,具有成本效益的系统。还将开发一个可应用于石蜡包埋的组织的替代,定量(Q)RT-PCR的平台。它将结合微阵列平台的基本信息,并允许评估未针对微阵列分析的标本中的关键参数,从而大大扩展了信息的实用性。有证据表明,遗传数据可能会为当前基因表达衍生的预后剂提供其他预后信息。我们建议在弥漫性大B细胞淋巴瘤上获得全面的高分辨率分子遗传数据,以检查遗传和基因表达参数的组合是否会改善当前的预后模型。由于现有的预后剂来自抗CD20治疗的档案案例的研究,因此将在接受当前治疗方案治疗的患者中重新评估它们。将进行修改以保持预后剂的准确性。这项研究不仅将验证先前定义的诊断和预后特征,而且还将进一步完善签名和算法,以提高准确性和鲁棒性。通过将信息调整为Q-RT-PCR平台,将扩展应用程序范围。通过合并遗传数据将增强预后剂,并通过重新评估接受当前治疗方案治疗的患者来进行更新。
项目成果
期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genome wide DNA-profiling of HIV-related B-cell lymphomas.
- DOI:10.1111/j.1365-2141.2009.07943.x
- 发表时间:2010-01
- 期刊:
- 影响因子:6.5
- 作者:Capello D;Scandurra M;Poretti G;Rancoita PM;Mian M;Gloghini A;Deambrogi C;Martini M;Rossi D;Greiner TC;Chan WC;Ponzoni M;Moreno SM;Piris MA;Canzonieri V;Spina M;Tirelli U;Inghirami G;Rinaldi A;Zucca E;Favera RD;Cavalli F;Larocca LM;Kwee I;Carbone A;Gaidano G;Bertoni F
- 通讯作者:Bertoni F
Oncogenically active MYD88 mutations in human lymphoma.
- DOI:10.1038/nature09671
- 发表时间:2011-02-03
- 期刊:
- 影响因子:64.8
- 作者:Ngo, Vu N.;Young, Ryan M.;Schmitz, Roland;Jhavar, Sameer;Xiao, Wenming;Lim, Kian-Huat;Kohlhammer, Holger;Xu, Weihong;Yang, Yandan;Zhao, Hong;Shaffer, Arthur L.;Romesser, Paul;Wright, George;Powell, John;Rosenwald, Andreas;Muller-Hermelink, Hans Konrad;Ott, German;Gascoyne, Randy D.;Connors, Joseph M.;Rimsza, Lisa M.;Campo, Elias;Jaffe, Elaine S.;Delabie, Jan;Smeland, Erlend B.;Fisher, Richard I.;Braziel, Rita M.;Tubbs, Raymond R.;Cook, J. R.;Weisenburger, Denny D.;Chan, Wing C.;Staudt, Louis M.
- 通讯作者:Staudt, Louis M.
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
- DOI:10.1056/nejmoa0905680
- 发表时间:2010-03-11
- 期刊:
- 影响因子:0
- 作者:Steidl C;Lee T;Shah SP;Farinha P;Han G;Nayar T;Delaney A;Jones SJ;Iqbal J;Weisenburger DD;Bast MA;Rosenwald A;Muller-Hermelink HK;Rimsza LM;Campo E;Delabie J;Braziel RM;Cook JR;Tubbs RR;Jaffe ES;Lenz G;Connors JM;Staudt LM;Chan WC;Gascoyne RD
- 通讯作者:Gascoyne RD
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
- DOI:10.1038/nature11378
- 发表时间:2012-10-04
- 期刊:
- 影响因子:64.8
- 作者:Schmitz, Roland;Young, Ryan M.;Ceribelli, Michele;Jhavar, Sameer;Xiao, Wenming;Zhang, Meili;Wright, George;Shaffer, Arthur L.;Hodson, Daniel J.;Buras, Eric;Liu, Xuelu;Powell, John;Yang, Yandan;Xu, Weihong;Zhao, Hong;Kohlhammer, Holger;Rosenwald, Andreas;Kluin, Philip;Mueller-Hermelink, Hans Konrad;Ott, German;Gascoyne, Randy D.;Connors, Joseph M.;Rimsza, Lisa M.;Campo, Elias;Jaffe, Elaine S.;Delabie, Jan;Smeland, Erlend B.;Ogwang, Martin D.;Reynolds, Steven J.;Fisher, Richard I.;Braziel, Rita M.;Tubbs, Raymond R.;Cook, James R.;Weisenburger, Dennis D.;Chan, Wing C.;Pittaluga, Stefania;Wilson, Wyndham;Waldmann, Thomas A.;Rowe, Martin;Mbulaiteye, Sam M.;Rickinson, Alan B.;Staudt, Louis M.
- 通讯作者:Staudt, Louis M.
Tissue microarray in a subset of South African patients with DLBCL.
南非 DLBCL 患者亚组的组织微阵列。
- DOI:10.1016/j.transci.2013.07.013
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Sissolak,Gerhard;Wood,Lucille;Smith,Lynette;Chan,JohnWingC;Armitage,James;Jacobs,Peter
- 通讯作者:Jacobs,Peter
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wing C. Chan其他文献
Large granular lymphocyte proliferation: an analysis of T-cell receptor gene arrangement and expression and the effect of in vitro culture with inducing agents.
大颗粒淋巴细胞增殖:T细胞受体基因排列和表达以及诱导剂体外培养效果的分析。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:20.3
- 作者:
Wing C. Chan;Carol DahI;Thomas A. Waldmann;Susan Link;Alison Mawle;Janet K. A. Nicholson;Fritz H. Bach;K. Bongiovanni;Peter A. McCue;Elliott F. Winton - 通讯作者:
Elliott F. Winton
Lymphomas of follicles. Mantle cell and follicle center cell lymphomas.
滤泡淋巴瘤。
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:3.5
- 作者:
D. Weisenburger;Wing C. Chan - 通讯作者:
Wing C. Chan
Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes.
大颗粒淋巴细胞增殖的异质性:两种主要亚型的划分。
- DOI:
- 发表时间:
1986 - 期刊:
- 影响因子:20.3
- 作者:
Wing C. Chan;A. Mawle;Irene J. Check;Russell K. Brynes;Elliott F. Winton - 通讯作者:
Elliott F. Winton
Mechanistic Elucidation of the Tumor-Promoting Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in B-Cell Receptor Signaling in Mantle Cell Lymphoma
- DOI:
10.1182/blood-2023-175064 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Serene Xavier;Vivian Nguyen;Vishal Khairnar;An Phan;Lu Yang;Michael Nelson;Elizabeth Tseng;Aimin Li;Joo Y Song;Dennis D. Weisenburger;Wing C. Chan;Markus Müschen;Vu N. Ngo - 通讯作者:
Vu N. Ngo
<em>PRDM1</em> Deletion and <em>STAT3</em> Mutations Cooperatively Promote CD8<sup>+</sup> T-Cell and NK-Cell Growth <em>in Vitro</em>
- DOI:
10.1182/blood-2022-168184 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Xuxiang Liu;Kunal Shetty;Yuping Li;Jibin Zhang;Alyssa C. Bouska;Javeed Iqbal;Giorgio Inghirami;Wing C. Chan - 通讯作者:
Wing C. Chan
Wing C. Chan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wing C. Chan', 18)}}的其他基金
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10300391 - 财政年份:2021
- 资助金额:
$ 36.93万 - 项目类别:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10491082 - 财政年份:2021
- 资助金额:
$ 36.93万 - 项目类别:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10672370 - 财政年份:2021
- 资助金额:
$ 36.93万 - 项目类别:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
生物分析物的分析前变量影响 PTCL 诊断和预后遗传特征的准确性
- 批准号:
10684317 - 财政年份:2021
- 资助金额:
$ 36.93万 - 项目类别:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10299140 - 财政年份:2021
- 资助金额:
$ 36.93万 - 项目类别:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
TET2 和 IDH2 突变在血管免疫母细胞 T 细胞淋巴瘤发生中的协同作用
- 批准号:
10453656 - 财政年份:2021
- 资助金额:
$ 36.93万 - 项目类别:
Development of a Novel Clinical Diagnostic Assay for Peripheral T-cell Lymphoma (PTCL)
开发外周 T 细胞淋巴瘤 (PTCL) 的新型临床诊断方法
- 批准号:
9555564 - 财政年份:2018
- 资助金额:
$ 36.93万 - 项目类别:
Molecular diagnostic and prognostic signatures for PTCL
PTCL 的分子诊断和预后特征
- 批准号:
10017897 - 财政年份:2017
- 资助金额:
$ 36.93万 - 项目类别:
Molecular diagnostic and prognostic signatures for PTCL
PTCL 的分子诊断和预后特征
- 批准号:
10226182 - 财政年份:2017
- 资助金额:
$ 36.93万 - 项目类别:
Gene expression profiling and pathway targeted therapy in peripheral T-cell
外周T细胞的基因表达谱和通路靶向治疗
- 批准号:
7715220 - 财政年份:2009
- 资助金额:
$ 36.93万 - 项目类别:
相似海外基金
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma
MLL2 基因失活在 B 细胞非霍奇金淋巴瘤中的作用
- 批准号:
8422377 - 财政年份:2013
- 资助金额:
$ 36.93万 - 项目类别:
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma
MLL2 基因失活在 B 细胞非霍奇金淋巴瘤中的作用
- 批准号:
8600247 - 财政年份:2013
- 资助金额:
$ 36.93万 - 项目类别:
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
侵袭性淋巴瘤的分子诊断和预后
- 批准号:
8090721 - 财政年份:2011
- 资助金额:
$ 36.93万 - 项目类别:
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
侵袭性淋巴瘤的分子诊断和预后
- 批准号:
8307807 - 财政年份:2011
- 资助金额:
$ 36.93万 - 项目类别:
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
侵袭性淋巴瘤的分子诊断和预后
- 批准号:
8504816 - 财政年份:2011
- 资助金额:
$ 36.93万 - 项目类别: